AQST
AQST
US03843E1047
Aquestive Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
599.95M EUR
522.13M EUR
515.78M EUR
Enterprise Value
557.98M EUR
482.67M EUR
448.63M EUR
Valuation Multiples
Trailing P/E
--
--
--
Forward P/E
-8.39x
--
--
Price to Sales
11.09x
9.65x
10.26x
Price to Book
--
--
--
EV/Revenue
10.32x
8.92x
8.92x
EV/EBITDA
-10.69x
--
--
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
-4.48%
-8.8%
-8.59%
ende